Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03385655
Title Prostate Cancer Biomarker Enrichment and Treatment Selection
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Canadian Cancer Trials Group
Indications

prostate adenocarcinoma

Therapies

Savolitinib

Darolutamide

Adavosertib

Age Groups: senior | adult
Covered Countries CAN


No variant requirements are available.